Desyncra Operating GmbH
Desyncra Operating GmbH develops and markets neuromodulation-based therapy for tinnitus relief.
About
Desyncra Operating GmbH specializes in neuroscientific therapy for tinnitus, offering a targeted, noninvasive treatment called Desyncra™ for Tinnitus. Their therapy utilizes CR (Coordinated Reset) Neuromodulation technology to disrupt abnormal hyperactivity in the neuronal networks of the auditory cortex, which are linked to tinnitus symptoms. The therapy is delivered through a customized iPod device with tailored earphones and therapeutic tones that are adjusted to the patient’s specific tinnitus profile. The mission is to provide sustained relief to patients with tinnitus, improve quality of life, and remain at the forefront of clinical research and technological development in neurological therapies.
Products & Services
- Desyncra™ for Tinnitus therapy
- CR® Neuromodulation technology
- Customized iPod therapy device and earphones
- Pitch-matching and therapy adjustment software
- Clinical training and support for providers
Use Cases & Case Studies
- 66-case study in the UK (Frontiers In Neurology 2015)
- 200-case study in Germany (BioMed Research International 2015)
- 27 cases in Hungary (Ideggyogyaszati Szemle 2015)
- 130 cases in Germany (Presented at XI International Tinnitus Seminar 2014)
- 63-case multi-centre trial in Germany (Restorative Neurology and Neuroscience 2012)
Partnerships & Collaborations
- Research at Stanford University
- Veterans Affairs Portland
- Clinical centers in England and Germany
Awards & Recognition
-